Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats
- PMID: 9309537
- DOI: 10.1007/BF03347990
Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats
Abstract
Glucocorticoids (GCs) suppress the hypothalamus-pituitary-adrenal (HPA) axis at various sites including hypothalamus, pituitary and extrahypothalamic brain. Previous studies have shown that corticotropin-releasing hormone (CRH) and vasopressin facilitate the recovery of HPA axis suppressed by GCs. In this study, we investigate whether the concomitant continuous infusion of CRH may prevent the suppression of HPA axis by GCs. Groups of male Wistar rats weighing 140 to 160 g were implanted subcutaneously with Alzet osmotic pump for delivery of dexamethasone (DEX), 2 micrograms/h and/or CRH, 0.66 microgram/h. Control rats were implanted with sialistic tube of similar size. Rats were decapitated 3 or 7 days after osmotic pump implantation. In spite of the suppression of plasma corticosterone, the body weight (BW), adrenal weight (AW), plasma corticotropin (ACTH) and pituitary ACTH content of rats treated with DEX for 3 days were not significantly different from those of control rats. Concomitant infusion of ovine CRH (oCRH) and DEX for 3 days caused impaired BW gain, adrenal atrophy in addition to further reduction of plasma corticosterone. Treatment with DEX and/or oCRH for 7 days caused further suppression of HPA axis as shown by reduced pituitary ACTH content. In conclusion, simultaneous infusion of oCRH and DEX does not prevent and may even worsen HPA axis suppression by DEX.
Similar articles
-
Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.Metabolism. 1994 May;43(5):544-8. doi: 10.1016/0026-0495(94)90193-7. Metabolism. 1994. PMID: 8177041
-
Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.Endocrinology. 1990 Oct;127(4):1574-9. doi: 10.1210/endo-127-4-1574. Endocrinology. 1990. PMID: 2169393
-
Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.Endocrinology. 1996 Nov;137(11):4935-43. doi: 10.1210/endo.137.11.8895366. Endocrinology. 1996. PMID: 8895366
-
Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.ScientificWorldJournal. 2006 Oct 31;6:1398-404. doi: 10.1100/tsw.2006.251. ScientificWorldJournal. 2006. PMID: 17086345 Free PMC article. Review.
-
Fetal hypothalamus-pituitary-adrenal axis on the road to parturition.Clin Exp Pharmacol Physiol. 2001 Jan-Feb;28(1-2):108-12. doi: 10.1046/j.1440-1681.2001.03412.x. Clin Exp Pharmacol Physiol. 2001. PMID: 11153525 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources